Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.19.3.a.u2
Condensed Consolidated Balance Sheets - USD ($)
Dec. 31, 2019
Jun. 30, 2019
Current assets    
Cash $ 18,780,897 $ 21,867,289
Restricted cash 500,000 500,000
Accounts receivable, net 1,753,935 1,257,274
Prepaid expenses and other assets 1,108,917 577,674
Total current assets 22,143,749 24,202,237
Investment 250,000
Total assets 22,393,749 24,202,237
Current liabilities    
Accounts payable 1,670,005 1,317,566
Accrued liabilities 564,348 500,550
Deferred revenue 844,554 624,387
Total current liabilities 3,078,907 2,442,503
Commitments and contingencies (Note 6)
Stockholders' equity:    
Preferred stock, par value $0.0001; 5,000,000 shares authorized, none are issued and outstanding at December 31, 2019 and June 30, 2019
Common stock, par value $0.0001; 75,000,000 shares authorized, 10,921,485 issued and outstanding at December 31, 2019, and 10,589,746 shares authorized, issued and outstanding at June 30, 2019 1,093 1,059
Additional paid-in capital 52,065,102 47,325,421
Accumulated deficit (32,751,353) (25,566,746)
Total stockholders' equity 19,314,842 21,759,734
Total liabilities and stockholders' equity $ 22,393,749 $ 24,202,237